Patents by Inventor Dezso S. Bartos

Dezso S. Bartos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4863853
    Abstract: The diagnostic value of monitoring serum-CEA-levels in a patient undergoing therapy for a cancerous tumor is determined by obtaining cytosole from the tumor and quantitatively determining its CEA content. Preferably, the cytosole used is obtained from a portion of the tumor used for hormone receptor analysis.
    Type: Grant
    Filed: April 14, 1983
    Date of Patent: September 5, 1989
    Assignee: Bartos Patent Development and Holding Company Limited
    Inventors: Dezso S. Bartos, Denis Fitzpatrick
  • Patent number: 4686194
    Abstract: The in-vivo effectiveness of cytostatic agents against immunological active tumors is determined by measuring immune markers and/or immune parameters in the serum before and up to 3 days after the application of the cytostatic agent. Preferably the deviation of coomplement binding capacity is used as immune parameter.
    Type: Grant
    Filed: April 14, 1983
    Date of Patent: August 11, 1987
    Assignee: Bartos Patent Development & Holding Company, Limited
    Inventors: Dezso S. Bartos, Denis Fitzpatrick